Novamind collaborates with Center for Change
Novamind has been collaborating with Center for Change (CFC), a specialty psychiatric hospital and leading treatment facility for eating disorders, on a study that examines the novel use of Novamind’s ketamine-assisted psychotherapy (“KAP”) protocols for treating several eating disorders. Currently, there aren’t any FDA-approved medication options available for individuals suffering from Anorexia Nervosa, which is serious and often debilitating. On April 8th, 2021, Center for Change held a webinar and, as the principal investigator for the study, and CFC’s Medical Director, I was privileged to share some of our early findings. Feel free to read Novamind’s press release or watch the CFC webinar linked here.
“Novamind is dedicated to researching, developing and delivering new therapeutic protocols to answer unmet needs in mental healthcare. Our treatment protocols are designed to improve patient outcomes, and we’re proud that renowned facilities like Center for Change recognize that we can provide new options for individuals struggling with eating disorders.”
